Technical Analysis for CYCN - Cyclerion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 2.57 1.98% 0.05
CYCN closed up 1.98 percent on Monday, April 6, 2020, on 46 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CYCN trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Bullish Engulfing Bullish 1.98%
Outside Day Range Expansion 1.98%
Wide Bands Range Expansion 1.98%
Oversold Stochastic Weakness 1.98%
Narrow Range Bar Range Contraction 8.44%
NR7 Range Contraction 8.44%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Cyclerion plans to advance its current portfolio of five differentiated sGC stimulator programs with distinct pharmacologic and biodistribution properties that are uniquely designed to target tissues of greatest relevance to the diseases they are intended to treat. These programs, each of which have important milestones in 2019, include olinciguat in Phase 2 development for sickle cell disease, praliciguat in Phase 2 trials for heart failure with preserved ejection fraction (HFpEF) and for diabetic nephropathy, IW-6463 in Phase 1 development for serious and orphan central nervous system diseases, and two late-stage discovery programs targeting serious liver and lung diseases, respectively.
Medicine Biopharmaceutical Medical Specialties Diseases Organ Systems Heart Failure Kidney Diseases Diabetic Nephropathy Sickle Cell Disease Cardiomyopathy

Is CYCN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.89
52 Week Low 1.69
Average Volume 452,106
200-Day Moving Average 6.44
50-Day Moving Average 3.58
20-Day Moving Average 2.80
10-Day Moving Average 2.83
Average True Range 0.44
ADX 14.12
+DI 23.72
-DI 22.97
Chandelier Exit (Long, 3 ATRs ) 2.91
Chandelier Exit (Short, 3 ATRs ) 3.40
Upper Bollinger Band 3.46
Lower Bollinger Band 2.13
Percent B (%b) 0.33
BandWidth 47.73
MACD Line -0.29
MACD Signal Line -0.27
MACD Histogram -0.0191
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.93
Resistance 3 (R3) 2.96 2.86 2.87
Resistance 2 (R2) 2.86 2.77 2.85 2.85
Resistance 1 (R1) 2.72 2.72 2.67 2.69 2.83
Pivot Point 2.62 2.62 2.60 2.61 2.62
Support 1 (S1) 2.48 2.53 2.43 2.45 2.31
Support 2 (S2) 2.38 2.48 2.37 2.29
Support 3 (S3) 2.24 2.38 2.27
Support 4 (S4) 2.21